iX Biopharma closes in on US military approval for pain drug
Halaman ini adalah ringkasan kurasi. Liputan lengkap ada di penerbit yang ditautkan di bawah. Kami tidak memuat ulang artikel mereka secara utuh.
The company says it expects to complete its Emergency Use Authorization submission in Q4 [SINGAPORE] iX Biopharma is clearing the path for its sublingual ketamine wafer to treat military casualties. . .
The company says it expects to complete its Emergency Use Authorization submission in Q4 [SINGAPORE] iX Biopharma is clearing the path for its sublingual ketamine wafer to treat military casualties af...(+1930 chars hidden)